John Lucius Arthur Cary Surpasses 8% Voting Rights in Arecor Therapeutics (AREC) via AJ Bell Custody
Arecor Therapeutics plc (AREC), the UK-based biopharmaceutical firm, has disclosed that John Lucius Arthur Cary has exceeded the 8% voting rights threshold. This notification, filed on 10 August 2026, relates to a transaction dated 7 August 2026 and complies with DTR5 regulations…
1 source
·7h ago